Do a good job in sales to attack the heart
Release time:
2020-07-22
To do a good job in sales, we should focus on
Pharmaceutical Company 2018 Outstanding Salesman Marketing Department of Shanghai Beika Pharmaceutical Technology Co., Ltd. Yan Jie
I have been working in Beika since I graduated from graduate school in 2013 , and it has been 5 years so far. From the initial marketing assistant, to the general manager assistant, to the marketing director, to the current sales manager. In fact, I personally feel that I have not made earth-shattering contributions to the company, but what I can guarantee is that I will do every job in my post with all my heart, try my best and ability to complete every task index, sum up experience in time, exchange and learn from others, and strive to do my best in my work.
2018 , with North Carolina joining Jianfeng Pharmaceutical, the overall strategic deployment and marketing strategy have changed, the sales task of the marketing department has increased, and my position has changed from managing myself to managing others. Personally, with the support and help of Mr. Li, he completed the sales target of Anhui Xinbeika, a subsidiary of Beika Pharmaceuticals, and made great contributions to the company's overall completion of the sales tasks of the group and the pharmaceutical industry. In addition, I also assist the marketing director to take on the daily management of sales and the layout of the sales team.
For sales, I always firmly believe that attacking the heart is the best, and I must do the following three points. First of all, we should not float on the surface. We should understand the needs of customers. From the perspective of customers, we should know the points that different customers care about. For example, Indian customers are more sensitive to price, while Japanese customers have higher requirements for indicators and systems. Secondly, there are always more ways than difficulties. If conditions permit, we should try our best to meet the requirements of customers and help them solve problems. Third, I always remember what our leaders told me that there should be a closed loop in doing things. That is to say, no matter whether it is big or small, and whether it is related to the order or not, communication with customers should be in place. No matter whether it can be done or not, we must give feedback to customers. If we can't do it, there must be reasonable reasons why we can't do it. Over time, customers will naturally have a sense of trust in me, and then the cooperation will be easier. But I know that what I have done is far from enough. All the past is a preface. I believe that I still have great potential and strive to make greater progress.
With the support of the group and the pharmaceutical industry, North Carolina is developing rapidly, and the sales department will face greater pressure in the future. I will continue to work hard in my position, do better, and work together with the company. Grow and work together to make the company more brilliant. (According to Yan Jie's speech at the summary and commendation meeting of the pharmaceutical company)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page